Brief: Biosyent Posts Q2 EPS Of C$0.05
23/08/2019 13:45
Aug 23 (Reuters) - Biosyent Inc RX.V :
* BIOSYENT RELEASES Q2 AND H1 2019 RESULTS
* Q2 EARNINGS PER SHARE C$0.05
* Q2 REVENUE FELL 13 PERCENT TO C$5.156 MILLION
* Q2 EARNINGS PER SHARE ESTIMATE C$0.11 -- REFINITIV IBES
DATA
Source text for Eikon: ID:nGNXbLvzvb
Further company coverage: RX.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biosyent
See all newsCanada's BioSyent Q2 revenue jumps 95% following Oral Health acquisition
Canada's BioSyent Q1 revenue rises helped by Oral Science acquisition
Brief: Biosyent Announces Closing Of The Acquisition Of Oral Science Inc.
Brief: Biosyent To Acquire Oral Science Inc.
Brief: Biosyent Announces Renewal Of Normal Course Issuer Bid